
Antibody evasion properties of SARS-CoV-2 Omicron sublineages
Abstract The identification of the Omicron variant (B.1.1.529.1 or BA.1) of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) in Botswana in November 20211 immediately raised alarms